Eikon

Eikon Therapeutics is a biopharmaceutical company that integrates Nobel Prize-winning super-resolution single-molecule tracking (SMT) microscopy, advanced engineering, automation, and high-performance computing to visualize and measure the real-time movement of individual proteins in living cells. This proprietary live-cell imaging platform screens protein-ligand interactions across millions of cells per day, generating large, high-dimensional datasets that power the discovery and development of novel small-molecule medicines. Eikon advances a clinical- and preclinical-stage oncology and immunology pipeline, including EIK1001 (a TLR7/8 agonist) and IMP1734 (a selective PARP1 inhibitor). Backed by General Catalyst, the company is headquartered in Millbrae, California with offices in New York and Jersey City.

Eikon is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Drug Discovery.

Eikon’s developer surface includes engineering blog, support, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiotechnologyPharmaceuticalsDrug DiscoveryOncologyLife SciencesMicroscopyMachine Learning

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/eikon: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 6

The organization behind the API

Website

About

Blog

Investors

Careers

LinkedIn

Other 2

Properties that don't map to a standard resource type

Platform

Platform

Pipeline

Pipeline

Source (apis.yml)

aid: eikon
name: Eikon
description: Eikon Therapeutics is a biopharmaceutical company that integrates Nobel Prize-winning super-resolution single-molecule
  tracking (SMT) microscopy, advanced engineering, automation, and high-performance computing to visualize and measure the
  real-time movement of individual proteins in living cells. This proprietary live-cell imaging platform screens protein-ligand
  interactions across millions of cells per day, generating large, high-dimensional datasets that power the discovery and
  development of novel small-molecule medicines. Eikon advances a clinical- and preclinical-stage oncology and immunology
  pipeline, including EIK1001 (a TLR7/8 agonist) and IMP1734 (a selective PARP1 inhibitor). Backed by General Catalyst, the
  company is headquartered in Millbrae, California with offices in New York and Jersey City.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.eikontx.com/wp-content/uploads/2024/11/metadata_social_thumbnail2.jpg
url: https://raw.githubusercontent.com/api-evangelist/eikon/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Healthcare
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Oncology
- Life Sciences
- Microscopy
- Machine Learning
apis: []
common:
- type: Website
  url: https://www.eikontx.com/
- type: About
  url: https://www.eikontx.com/about-us/
- type: Platform
  url: https://www.eikontx.com/platform/
- type: Pipeline
  url: https://www.eikontx.com/pipeline/
- type: Blog
  url: https://www.eikontx.com/news/
- type: Support
  url: https://www.eikontx.com/contact/
- type: PrivacyPolicy
  url: https://www.eikontx.com/privacy-policy/
- type: Investors
  url: https://investors.eikontx.com/
- type: Careers
  url: https://www.eikontx.com/join-us/
- type: LinkedIn
  url: https://www.linkedin.com/company/eikon-therapeutics-inc/
- type: DomainSecurity
  url: security/eikon-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence